Chronicle Journal: Finance

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Merck & Co (NY: MRK )

80.85 USD -0.13 (-0.16%)
Streaming Delayed Price Updated: 3:36 PM EST, Jan 25, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 6,276,066
Open 80.71
Bid (Size) 80.84 (2)
Ask (Size) 80.85 (3)
Prev. Close 80.98
Today's Range 80.06 - 81.19
52wk Range 65.25 - 89.20
Shares Outstanding 2,690,303,898
Dividend Yield 2.37%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Merck Canada and MaRS Team Up to Launch Lung Cancer Innovation Challenge
From PR Newswire
Merck Discontinues Development of SARS-CoV-2/COVID-19 Vaccine Candidates; Continues Development of Two Investigational Therapeutic Candidates
Merck Discontinues Development of SARS-CoV-2/COVID-19 Vaccine Candidates; Continues Development of Two Investigational Therapeutic Candidates 
From Business Wire News Releases

Performance

YTD
-0.14%
-0.14%
1 Month
+0.50%
+0.50%
3 Month
+2.55%
+2.55%
6 Month
+2.43%
+2.43%
1 Year
-6.10%
-6.10%

More News

Read More
ROCE Insights For Merck & Co
Tags BZI/ROCE News MRK
From Benzinga
Biden to reinstate travel bans amid fears about new variants as global case tally heads toward 100 million
Tags General BNTX MRK
From MarketWatch
Thinking about trading options or stock in Niu Technologies, Regeneron Pharmaceuticals, General Electric, Merck, or Axon Enterprise?
From PR Newswire
Merck Drops COVID-19 Vaccine Studies After Phase 1 Data Churn Out Inferior Efficacy Results
Tags News Health Care Coronavirus
From Benzinga
Merck Announces U.S. FDA Approval of VERQUVO® (vericiguat)
From Business Wire News Releases
Merck Scraps Development Of 'Inferior' Covid Vaccines; Shares Dip
From Investor's Business Daily
Implied FTXH Analyst Target Price: $30
Tags ETFs
From ETF Channel
Merck Ends Work On COVID-19 Vaccines, Still Working On Therapeutic Candidates
Tags Stocks / Equities Pharma/Biotech Healthcare
From Blogs - TalkMarkets
Dow Jones Today, Futures Mixed As Merck Exits Covid Vaccine Race; Apple, Microsoft, AMD Rise Ahead Of Earnings
From Investor's Business Daily
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

© Copyright 2015, Chronicle Journal, Thunder Bay, ON. Powered by BLOX Content Management System from TownNews.com. [Terms of Use | Privacy Policy]